Nuvalent Market Capitalization from 2010 to 2025
| NUVL Stock | USD 76.88 1.15 1.47% |
Check Nuvalent financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nuvalent's main balance sheet or income statement drivers, such as Depreciation And Amortization of 28.1 M, Interest Expense of 28.1 M or Selling General Administrative of 43.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.78. Nuvalent financial statements analysis is a perfect complement when working with Nuvalent Valuation or Volatility modules.
Nuvalent | Market Capitalization |
Latest Nuvalent's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Nuvalent over the last few years. It is Nuvalent's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nuvalent's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 5.39 B | 10 Years Trend |
|
Market Cap |
| Timeline |
Nuvalent Market Capitalization Regression Statistics
| Arithmetic Mean | 1,000,595,514 | |
| Geometric Mean | 982,589,510 | |
| Coefficient Of Variation | 21.57 | |
| Mean Deviation | 160,964,486 | |
| Median | 905,324,419 | |
| Standard Deviation | 215,858,129 | |
| Sample Variance | 46594.7T | |
| Range | 637.3M | |
| R-Value | 0.52 | |
| Mean Square Error | 36205.5T | |
| R-Squared | 0.27 | |
| Significance | 0.04 | |
| Slope | 23,766,249 | |
| Total Sum of Squares | 698921T |
Nuvalent Market Capitalization History
About Nuvalent Financial Statements
Nuvalent investors utilize fundamental indicators, such as Market Capitalization, to predict how Nuvalent Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts. Nuvalent Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Nuvalent Correlation against competitors. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.